Abstract

The emergence of benchtop sequencers has made clinical genetic testing using next-generation sequencing more feasible. Ion Torrent's PGMTM is one such benchtop sequencer that shows clinical promise in detecting single nucleotide variations (SNVs) and microindel variations (indels). However, the large number of false positive indels caused by the high frequency of homopolymer sequencing errors has impeded PGMTM's usage for clinical genetic testing. An extensive analysis of PGMTM data from the sequencing reads of the well-characterized genome of the Escherichia coli DH10B strain and sequences of the BRCA1 and BRCA2 genes from six germline samples was done. Three commonly used variant detection tools, SAMtools, Dindel, and GATK's Unified Genotyper, all had substantial false positive rates for indels. By incorporating filters on two major measures we could dramatically improve false positive rates without sacrificing sensitivity. The two measures were: B-Allele Frequency (BAF) and VARiation of the Width of gaps and inserts (VARW) per indel position. A BAF threshold applied to indels detected by UnifiedGenotyper removed ∼99% of the indel errors detected in both the DH10B and BRCA sequences. The optimum BAF threshold for BRCA sequences was determined by requiring 100% detection sensitivity and minimum false discovery rate, using variants detected from Sanger sequencing as reference. This resulted in 15 indel errors remaining, of which 7 indel errors were removed by selecting a VARW threshold of zero. VARW specific errors increased in frequency with higher read depth in the BRCA datasets, suggesting that homopolymer-associated indel errors cannot be reduced by increasing the depth of coverage. Thus, using a VARW threshold is likely to be important in reducing indel errors from data with higher coverage. In conclusion, BAF and VARW thresholds provide simple and effective filtering criteria that can improve the specificity of indel detection in PGMTM data without compromising sensitivity.

Highlights

  • Recent years have witnessed a rapid increase in the utilization of next-generation sequencing (NGS) technology for clinical genetic testing [1,2,3,4,5,6]

  • DH10B sequence data generated on the PGMTM and aligned with the Torrent Suite had zero single nucleotide variations (SNVs) and 42 indels detected using SAMtools (Table 1)

  • We investigated the characteristics of homopolymer associated indel errors derived from one such technology, the Ion Torrent PGMTM, and suggest a solution to reduce the false positive rate for indels

Read more

Summary

Introduction

Recent years have witnessed a rapid increase in the utilization of next-generation sequencing (NGS) technology for clinical genetic testing [1,2,3,4,5,6]. Benchtop high-throughput sequencers such as the Ion Torrent PGMTM from Life Technologies and the MiSeq from Illumina have emerged as the latest options for genome resequencing [11,12]. Their lower start-up costs and simpler sample preparation promise to reduce the reliance on core genome facilities and are likely to spur the use of NGS in clinical genetic testing. The PGMTM produces high frequencies of homopolymer sequencing errors [14]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call